Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy
Clinical trial NCT04811716 · COMPLETED
Trial details
- NCT number
- NCT04811716
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-29
- Primary completion
- 2022-10-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.